Chinese Journal of Pathology 2010;39(4):218-221
Clinical significance and pathological evaluation of neoadjuvant chemotherapy in breast cancer.
Li-rong CHEN
MeSH
Antibodies, Monoclonal;
therapeutic use;
Antibodies, Monoclonal, Humanized;
Antineoplastic Agents;
therapeutic use;
Antineoplastic Agents, Hormonal;
therapeutic use;
Antineoplastic Agents, Phytogenic;
therapeutic use;
Breast Neoplasms;
drug therapy;
pathology;
ultrastructure;
Carcinoma, Ductal, Breast;
drug therapy;
pathology;
ultrastructure;
Chemotherapy, Adjuvant;
Female;
Humans;
Neoadjuvant Therapy;
Nitriles;
therapeutic use;
Taxoids;
therapeutic use;
Trastuzumab;
Treatment Outcome;
Triazoles;
therapeutic use
备案号: 11010502037788, 京ICP备10218182号-8)